JPH026511B2 - - Google Patents

Info

Publication number
JPH026511B2
JPH026511B2 JP58139384A JP13938483A JPH026511B2 JP H026511 B2 JPH026511 B2 JP H026511B2 JP 58139384 A JP58139384 A JP 58139384A JP 13938483 A JP13938483 A JP 13938483A JP H026511 B2 JPH026511 B2 JP H026511B2
Authority
JP
Japan
Prior art keywords
culture
hours
units
culture solution
penicillin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58139384A
Other languages
Japanese (ja)
Other versions
JPS6030677A (en
Inventor
Juzo Udaka
Hideo Kamyama
Junichi Taniguchi
Keiji Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shikishima Boseki KK
Original Assignee
Shikishima Boseki KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shikishima Boseki KK filed Critical Shikishima Boseki KK
Priority to JP13938483A priority Critical patent/JPS6030677A/en
Priority to CA000459394A priority patent/CA1237085A/en
Priority to GB08418745A priority patent/GB2146028B/en
Priority to AU31000/84A priority patent/AU572529B2/en
Priority to DE19843428017 priority patent/DE3428017A1/en
Priority to CH3684/84A priority patent/CH663033A5/en
Priority to KR1019840004559A priority patent/KR850002276A/en
Priority to NL8402388A priority patent/NL8402388A/en
Priority to FR8412119A priority patent/FR2550223B1/en
Priority to SE8403914A priority patent/SE461532B/en
Publication of JPS6030677A publication Critical patent/JPS6030677A/en
Priority to US06/746,514 priority patent/US4656037A/en
Publication of JPH026511B2 publication Critical patent/JPH026511B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】 本発明は、ストレプトコツカス属細菌の各種有
効成分を菌体外に排出させる培養法に関するもの
である。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a culture method for excreting various active ingredients of Streptococcus bacteria to the outside of the cells.

更に詳細には、本発明は、ストレプトコツカス
属細菌の培養中にペニシリン又はその関連物質を
添加し、培養を行うことによつて各種菌体生産物
を菌体外に排出させ、培地中に蓄積させる方法に
関するものである。
More specifically, the present invention involves adding penicillin or its related substances during the cultivation of Streptococcus bacteria, and culturing to expel various bacterial cell products from the bacterial cells, and adding them to the culture medium. This relates to a method of accumulating information.

従来、溶連菌(Streptococcus pyogenes)の
生菌体を弱毒化して製剤化したものは、すでに制
癌剤として使用されている。
Conventionally, preparations prepared by weakening viable cells of Streptococcus pyogenes have already been used as anticancer agents.

また、ストレプトコツカス・ピオゲネスの菌体
を破砕後、水または塩類溶液で有効成分を抽出
し、有機溶媒を加えて、抗種瘍性成分を沈澱とし
て、回収する方法(特公昭38−1647)、溶連菌を
溶菌酵素、リゾチーム、セルラーゼまたは、蛋白
質分解酵素により、溶菌し、活性画分を水溶性区
分として分画する方法(英国特許第1163865号)
などが知られている。
Another method is to crush the bacterial cells of Streptococcus pyogenes, extract the active ingredients with water or a salt solution, add an organic solvent, and collect the anti-seed ingredients as a precipitate (Japanese Patent Publication No. 1647-1971). , a method of lysing hemolytic streptococci with a lytic enzyme, lysozyme, cellulase, or proteolytic enzyme and fractionating the active fraction as a water-soluble fraction (British Patent No. 1163865)
etc. are known.

このように、ストレプトコツカス属細菌そのも
のもしくはその菌体成分に抗腫瘍活性があること
は広く知られているのであるが、従来知られたも
のは、菌体もしくは可溶性もしくは、不溶性高分
子細胞構成物質であるに過ぎなかつた。菌体もし
くは菌体内から有効成分を単離しようとすれば、
菌体を溶菌したり、機械的に破砕したりして全体
を分画しなければならなかつた。このような処理
によれば、精製は複雑となり、有効成分の単離は
きわめて困難であつた。実際に分離し、有効成分
として測定された例では分子量150000の蛋白質が
知られています。(特公昭48−43841) 本発明者らは、ストレプトコツカス属細菌の生
産する各種菌体生産物を培養中に、菌体外に排出
させることができれば、その精製はかなり容易な
ものとなり、更にはより有用な生理活性物質を見
出し得るとの想定のもとに、培養法の改良につい
て鋭意研究した結果、培養中にペニシリンを添加
することによつて、菌体生産物を菌体外に排出さ
せることに成功したのである。
As described above, it is widely known that Streptococcus bacteria themselves or their bacterial cell components have antitumor activity, but what was previously known was that the Streptococcus bacteria themselves or their bacterial cell components have antitumor activity. It was nothing more than matter. If you try to isolate the active ingredient from the bacterial body or inside the bacterial body,
It was necessary to fractionate the entire bacterial body by lysing it or mechanically crushing it. Such treatment complicates purification and makes it extremely difficult to isolate the active ingredient. An example of a protein that has actually been isolated and measured as an active ingredient is known to have a molecular weight of 150,000. (Japanese Patent Publication No. 48-43841) The present inventors have discovered that if various bacterial cell products produced by Streptococcus bacteria can be excreted outside the bacterial cells during cultivation, their purification will be considerably easier. Furthermore, based on the assumption that more useful physiologically active substances could be discovered, as a result of intensive research into improving culture methods, we found that by adding penicillin during culture, we were able to remove bacterial cell products from the bacterial cells. They succeeded in ejecting it.

本発明は、ストレプトコツカス属に属する細菌
を培養するに際し、培養中の適当な時期にペニシ
リン又はその関連物質を添加して培養し、各種菌
体生産物を菌体外に排出せしめることを特徴とす
るストレプトコツカス属細菌の培養法である。
The present invention is characterized in that, when culturing bacteria belonging to the genus Streptococcus, penicillin or a related substance is added at an appropriate time during the culture, and various bacterial products are excreted outside the bacteria. This is a method for culturing Streptococcus bacteria.

本発明の方法においては、ストレプトコツカス
属細菌の生産する各種菌体生産物は菌体外に排出
され、培養液中に存在するようになるので、菌体
を過して除去し、培養液を精製すればよいの
で、単離はかなり容易なものとなる。
In the method of the present invention, various bacterial cell products produced by Streptococcus bacteria are excreted outside the bacterial cells and become present in the culture solution. Isolation is quite easy since all you have to do is purify it.

従来、ストレプトコツカス属細菌を培養し、得
られた菌をペニシリンで処理して弱毒化させる方
法は知られているが、培養中にペニシリンを添加
して、菌体生産物を菌体外に排出させる方法につ
いては全く知られていない。
Conventionally, it is known to culture Streptococcus bacteria and attenuate the resulting bacteria by treating them with penicillin. There is no known method of evacuation.

本発明の方法においては、ストレプトコツカス
属細菌であれば広く使用することができる。例示
すれば、次の通りである Streptococcus pyogenes ATCC21060 Streptococcus SP. ATCC21597 Streptococcus pyogenes ATCC21546 Streptococcus pyogenes ATCC21547 Streptococcus pyogenes ATCC21548 培養液は、肉エキス培地、酵母エキス培地、ブ
レイン・ハート・インフユージヨン培地(BHI
培地)等の天然培地がよく用いられるが、ストレ
プトコツカス属細菌が有効に生育する培地であれ
ば、炭素源、窒素源等含んだ一般培地も使用する
ことができる。
In the method of the present invention, a wide variety of bacteria of the genus Streptococcus can be used. For example, Streptococcus pyogenes ATCC21060 Streptococcus SP. ATCC21597 Streptococcus pyogenes ATCC21546 Streptococcus pyogenes ATCC21547 Streptococcus pyogenes ATCC21548
Natural media such as Streptococcus spp.) are often used, but general media containing carbon sources, nitrogen sources, etc. can also be used as long as they allow Streptococcus bacteria to grow effectively.

培養はストレプトコツカス属細菌が生育する条
件が選ばれるが、PH6.0〜8.0、好ましくは6.8〜
7.2で30〜40℃好ましくは35〜37℃であり嫌気的
に静置培養をおこなうのが一般的であるが、その
他撹拌培養等の変法も採用することができる。
Cultivation conditions are selected under which bacteria of the genus Streptococcus grow, with a pH of 6.0 to 8.0, preferably 6.8 to 8.0.
7.2, it is common to perform static culture at 30 to 40°C, preferably 35 to 37°C, in an anaerobic manner, but other modified methods such as stirring culture can also be adopted.

本発明においては、培養中の適宜時期にペニシ
リン又はその関連物質を添加することによつて菌
体が生産する各種有用物質を菌体外に排出させ、
培養中に蓄積させることができるようになるもの
である。
In the present invention, by adding penicillin or a related substance at an appropriate time during culture, various useful substances produced by the bacterial cells are excreted outside the bacterial cells,
This allows it to accumulate during culture.

ペニシリン又はその関連物質としてはすでに知
られたペニシリンと類似の作用をもつ関連物質で
あればいかなるものでもよいが、ペニシリンGが
普通用いられる。添加量はペニシリンGで100〜
3000単位/ml、好ましくは1000単位/ml培養液程
度で十分である。
Penicillin or its related substances may be any known related substances that have similar effects to penicillin, but penicillin G is commonly used. The amount added is 100~ for penicillin G.
About 3000 units/ml, preferably 1000 units/ml of culture solution is sufficient.

ペニシリン又はその関連物質の添加時期は37℃
の培養で対数増殖期にかかつて後3〜15時間の
間、特に5〜10時間が好ましい。その後1時間乃
至20時間、好ましくは5〜15時間そのまま培養を
続けることによつて、培養液中に菌体生産物を多
量に蓄積させることができる。
The timing of addition of penicillin or related substances is 37℃.
A period of 3 to 15 hours, particularly 5 to 10 hours after the culture reaches logarithmic growth phase is preferred. By continuing the culture for 1 to 20 hours, preferably 5 to 15 hours, a large amount of bacterial cell products can be accumulated in the culture solution.

本発明はストレプトコツカス属細菌の菌体から
菌体生産物を菌体外に排出させる方法を提案する
もので、排出される菌体生産物はいかなるもので
もよく、必要によつて培養液から各種有用物質が
分離される。
The present invention proposes a method for expelling bacterial cell products from the bacterial cells of Streptococcus bacteria.Any bacterial cell products may be discharged, and if necessary, the bacterial cell products may be discharged from the culture solution. Various useful substances are separated.

得られた培養液は、遠心分離によつて菌体を分
離し、液に硫安を添加し、沈澱物として有効成
分を得ることができる。
The bacterial cells are separated from the obtained culture solution by centrifugation, ammonium sulfate is added to the solution, and the active ingredient can be obtained as a precipitate.

沈澱物は凍結状態で保存することができ、必要
によつて、イオン交換樹脂、ゲル過材、等を組
合せた精製法によつて精製して行くことができ
る。
The precipitate can be stored in a frozen state and, if necessary, purified by a purification method that combines an ion exchange resin, a gel filtration material, etc.

菌株によつて生産物は変化し、種々の物質を分
離することができるが、次に本発明方法によつて
Streptocaccus pyogenes ATCC21060から抗菌
性ならびに抗腫瘍性を有する各種菌体生産物が培
地中に排出蓄積される。例えばその一つとして次
のような理化学的性質を有する生理活性物質SPF
−1が得られた。
The products vary depending on the strain, and various substances can be separated, but by the method of the present invention,
Various bacterial cell products having antibacterial and antitumor properties are excreted and accumulated in the medium from Streptocaccus pyogenes ATCC21060. For example, SPF is a physiologically active substance with the following physical and chemical properties.
-1 was obtained.

1 元素分析 2 分子量 ゲル過法による測定では、分子量約500〜
7000である。
1 Elemental analysis 2 Molecular weight When measured by gel filtration method, the molecular weight is about 500~
It is 7000.

3 分解点 本物質は170℃で褐変し、200℃になると黒色
となり分解する。
3. Decomposition point This substance turns brown at 170℃ and turns black at 200℃ and decomposes.

4 比旋光度 〔α〕20 D=+63.3〜64.3゜(C=1.04) 5 紫外線吸収スペクトル 本物質の3.3%の水溶液の紫外線吸収スペク
トルは第1図に示され、3.1%の水溶液の紫外
線吸収スペクトルは第2図に示される。いずれ
も、257nm、265nm、280nm、287nmに吸収
がみられ、特徴的である。
4 Specific rotation [α] 20 D = +63.3 to 64.3° (C = 1.04) 5 Ultraviolet absorption spectrum The ultraviolet absorption spectrum of a 3.3% aqueous solution of this substance is shown in Figure 1, and the ultraviolet absorption spectrum of a 3.1% aqueous solution The absorption spectrum is shown in FIG. All have characteristic absorption at 257 nm, 265 nm, 280 nm, and 287 nm.

6 赤外線吸収スペクトル 第3図に示される。6 Infrared absorption spectrum It is shown in FIG.

7 溶剤に対する溶解性 水に可溶であるが、メタノール、エタノー
ル、n−ブタノール、イソブタノール、n−プ
ロパノール、n−ヘキサン、クロロホルム、ア
セトン、メチルイソブチルケトン、エチルエー
テル等の溶剤には不溶である。
7 Solubility in solvents Soluble in water, but insoluble in solvents such as methanol, ethanol, n-butanol, isobutanol, n-propanol, n-hexane, chloroform, acetone, methyl isobutyl ketone, and ethyl ether. .

8 塩基性、酸性、中性の区別 本物質の0.85%水溶液のPHは6.5である。8 Distinction between basic, acidic, and neutral The pH of a 0.85% aqueous solution of this substance is 6.5.

9 物質の色 白色粉末状である。9 Color of matter It is a white powder.

10 呈色反応 ニンヒドリン反応 + ビユウレツト反応 + モーリツシユ反応 − デイシエ反応 − アンスロン反応 − システイン硫酸反応 − 11 安定化 本物質はL−システイン、ジチオスレイトー
ル(DTT)、グリセロール、アルブミン、グロ
ブリン(NH42SO4、食塩等の添加によつて安
定化される。
10 Color reaction Ninhydrin reaction + Bieurets reaction + Mauritsch reaction - Decier reaction - Anthrone reaction - Cysteine sulfate reaction - 11 Stabilization This substance contains L-cysteine, dithiothreitol (DTT), glycerol, albumin, globulin (NH 4 ) 2 It is stabilized by adding SO 4 , salt, etc.

次に本発明の実施例を示す。 Next, examples of the present invention will be shown.

なお実施例における生理活性物質SPF−1の活
性単位の測定は鵜高法(Journal of Antibiotics
Vol35No.10 1319〜1325OCT.1982)によつた。測
定には高分子透過性大腸菌変異株MP−2
(FERM−P5432)(Agric.Biol.Chem.、43、371
(1979)を使用してMP−2に対する抗菌活性を
指標としてバイオ・アツセイする。
In the Examples, the activity unit of the physiologically active substance SPF-1 was measured using the Udaka method (Journal of Antibiotics
Vol35No.10 1319-1325OCT.1982). For measurement, polymer-permeable E. coli mutant strain MP-2 was used.
(FERM−P5432) (Agric.Biol.Chem., 43, 371
(1979) to conduct a bioassay using antibacterial activity against MP-2 as an indicator.

すなわち、バクト・アンチバイオチツクメデイ
アム3(デイフコ社製品)1.75%、寒天1.3%より
成る培地(M3培地)を120℃、15分加熱設定し、
20mlずつシヤーレに分注し、放置してプレート培
地を調製する。
That is, a medium (M3 medium) consisting of 1.75% Bacto Antibiotic Medium 3 (product of Difco) and 1.3 % agar was heated at 120°C for 15 minutes.
Dispense 20 ml into a shear dish and leave to prepare a plate medium.

一方、ペプトン0.5%、肉エキス0.5%、
NaCl0.3%、寒天0.8%より成る培地を120℃、15
分加熱放置する。その後42℃の恒温槽に保ち、培
地の温度が42℃になつたらあらかじめ37℃で17時
間培養したMP−2菌を1ml中に104個の細胞が
存在する様に培地中に加える。ピペツトによつて
2mlを採取し、あらかじめ作製して置いたM3
地表面上に加え、すばやく均一にひろげ固化させ
る。生理活性物質SPF−1を含む被膜層を適当に
希釈して、その溶液0.05mlをペーパー・デイスク
(直径8mm)(東洋紙)にしみ込ませる。このペ
ーパー・デイスクを前記作製プレート上に置き、
37℃で17時間培養し、生理活性物質SPF−1によ
つてできる阻止円の大きさを確定する。阻止円の
直径10mmを与えるSPF−1の濃度を1単位(1u)
と定義する。
Meanwhile, peptone 0.5%, meat extract 0.5%,
A medium consisting of 0.3% NaCl and 0.8% agar was heated at 120℃ for 15 minutes.
Leave to heat for a minute. Thereafter, the medium is kept in a constant temperature bath at 42°C, and when the temperature of the medium reaches 42°C, MP-2 bacteria that have been previously cultured at 37°C for 17 hours are added to the medium so that 10 4 cells are present in 1 ml. Collect 2 ml with a pipette, add it to the surface of the M3 medium prepared in advance, and spread it quickly and uniformly to solidify. The coating layer containing the physiologically active substance SPF-1 was diluted appropriately, and 0.05 ml of the solution was soaked into a paper disk (8 mm in diameter) (Toyo Shi). Place this paper disk on the production plate,
After culturing at 37°C for 17 hours, the size of the inhibition zone created by the physiologically active substance SPF-1 was determined. 1 unit (1u) concentration of SPF-1 that gives a diameter of inhibition circle of 10mm
It is defined as

実施例 1 次の組成の培地A2lに、 肉エキス 1% ポリペプトン 1% NaCl 0.5% PH=7.1 Streptococcus pyogenes ATCC21060を
(BHI培地100mlに接種して37℃、8時間静置培
養により前培養をおこなつた培養液100mlを)接
種し、37℃、15hr撹拌しながら嫌気的に培養後、
ペニシリンG1000単位/mlを添加し、更に培養を
5hr継続する。得られた培養液を遠心分離し、菌
体を除去した。
Example 1 Meat extract 1% Polypeptone 1% NaCl 0.5% PH = 7.1 Streptococcus pyogenes ATCC21060 was inoculated into 100 ml of BHI medium and precultured by static culture at 37°C for 8 hours in A2L medium with the following composition. After inoculating 100ml of culture solution (100ml) and culturing anaerobically at 37℃ for 15 hours with stirring,
Add 1000 units/ml of penicillin G and further culture.
Continues for 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が120単
位/ml含有されていた。
The culture solution contained 120 units/ml of the physiologically active substance SPF-1.

実施例 2 次の組成の培地B2lに、 酵母エキス 3.0% BHI 1.0% ポリペプトン 1.0% マルトース 0.3% KH2PO4 0.1% MgSO4・7H2O 0.02% PH=7.2 Streptococcus pyogenes ATCC21060を実施
例1と同様に、前培養した培養液100mlを接種し、
37℃、15hr撹拌しながら嫌気的に培養後、ペニシ
リンG1000単位/mlを添加し、更に培養を5hr継
続する。得られた培養液を遠心分離し、菌体を除
去した。
Example 2 Yeast extract 3.0% BHI 1.0% Polypeptone 1.0% Maltose 0.3% KH 2 PO 4 0.1% MgSO 4 7H 2 O 0.02% PH = 7.2 Streptococcus pyogenes ATCC 21060 was added to B2L medium with the following composition as in Example 1. Inoculate 100ml of precultured culture solution into
After culturing anaerobically at 37°C for 15 hours with stirring, 1000 units/ml of penicillin G was added, and the culture was continued for an additional 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が152単
位/ml含有されていた。
The culture solution contained 152 units/ml of the physiologically active substance SPF-1.

実施例 3 次の組成の培地C2lに、 肉エキス 1% ポリペプトン 1% NaCl 0.5% マルトース 0.3% KH2PO4 0.1% MgSO4・7H2O 0.02% PH=7.1 Streptococcus pyogenes ATCC21060を実施
例1と同様に前培養した培養液100mlを接種し、
37℃、15hr撹拌しながら嫌気的に培養後、ペニシ
リンG1000単位/mlを添加し、更に培養を5hr継
続する。得られた培養液を遠心分離し、菌体を除
去した。
Example 3 Meat extract 1% Polypeptone 1% NaCl 0.5% Maltose 0.3% KH 2 PO 4 0.1% MgSO 4 7H 2 O 0.02% PH = 7.1 Streptococcus pyogenes ATCC 21060 was added in the same manner as in Example 1 to a medium C2l with the following composition. Inoculate 100ml of precultured culture solution into
After culturing anaerobically at 37°C for 15 hours with stirring, 1000 units/ml of penicillin G was added, and the culture was continued for an additional 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が240単
位/ml含有されていた。
The culture solution contained 240 units/ml of the physiologically active substance SPF-1.

実施例 4 次の組成の培地D2lに、 肉エキス 1.5% ポリペプトン 1.0% NaCl 0.5% カザミノ酸 0.5% 酵母エキス 0.2% PH=7.1 Streptococcus pyogenes ATCC21060を実施
例1と同様に前培養した培養液100mlの−20℃保
存物を接種し、37℃、15hr撹拌しながら嫌気的に
培養後、ペニシリンG1000単位/mlを添加し、更
に培養を5hr継続する。得られた培養液を遠心分
離し、菌体を除去した。
Example 4 100 ml of a culture medium with the following composition: meat extract 1.5% polypeptone 1.0% NaCl 0.5% casamino acids 0.5% yeast extract 0.2% PH = 7.1 Streptococcus pyogenes ATCC21060 was precultured in the same manner as in Example 1. After inoculating the cells stored at 20°C and anaerobically cultivating them at 37°C for 15 hours with stirring, 1000 units/ml of penicillin G was added, and the culture was continued for an additional 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が108単
位/ml含有されていた。
The culture solution contained 108 units/ml of the physiologically active substance SPF-1.

実施例 5 次の組成の培地E2lに、 肉エキス 1.5% ポリペプトン 1.0% NaCl 0.5% カザミノ酸 0.25% 酵母エキス 0.25% PH=7.1 Streptococcus pyogenes ATCC21060を実施
例1と同様に前培養した種培養液100mlを接種し、
37℃、15hr撹拌しながら嫌気的に培養後、ペニシ
リンG1000単位/mlを添加し、更に培養を5hr継
続する。得られた培養液を遠心分離し、菌体を除
去した。
Example 5 Meat extract 1.5% Polypeptone 1.0% NaCl 0.5% Casamino acids 0.25% Yeast extract 0.25% PH = 7.1 100 ml of the seed culture solution obtained by pre-cultivating Streptococcus pyogenes ATCC21060 in the same manner as in Example 1 was added to medium E2l with the following composition. inoculate,
After culturing anaerobically at 37°C for 15 hours with stirring, 1000 units/ml of penicillin G was added, and the culture was continued for an additional 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が180単
位/ml含有されていた。
The culture solution contained 180 units/ml of the physiologically active substance SPF-1.

実施例 6 前記培地E2lに Streptococcus pyogenes ATCC21060を実施
例1と同様に前培養した培養液100mlの−20℃保
存物を接種し、37℃、15hr撹拌しながら嫌気的に
培養後、ペニシリンG1000単位/mlを添加し、更
に培養を5hr継続する。得られた培養液を遠心分
離し、菌体を除去した。
Example 6 Streptococcus pyogenes ATCC21060 was precultured in the same manner as in Example 1, and 100 ml of the culture solution stored at -20°C was inoculated into the E2l medium. After culturing anaerobically at 37°C for 15 hours with stirring, 1000 units of penicillin G/ ml and continue culturing for an additional 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が100単
位/ml含有されていた。
The culture solution contained 100 units/ml of the physiologically active substance SPF-1.

実施例 7 下記の培地F2lに、 肉エキス 3.0% ポリペプトン 1.0% NaCl 0.5% カザミノ酸 0.5% PH=7.1 Streptococcus pyogenes ATCC21060を実施
例1と同様にして前培養した培養液100mlの−20
℃保存物を、接種し、37℃、5.5hr撹拌しながら
嫌気的に培養後、ペニシリンG1000単位/mlを添
加し、更に培養を15hr継続する。得られた培養液
を遠心分離し、菌体を除去した。
Example 7 Meat extract 3.0% Polypeptone 1.0% NaCl 0.5% Casamino acids 0.5% PH = 7.1 Streptococcus pyogenes ATCC21060 was precultured in the same manner as in Example 1, and 100 ml of the culture solution -20 was added to the following medium F2l.
After inoculating the culture at 37° C. and culturing anaerobically with stirring for 5.5 hours, 1000 units/ml of penicillin G was added, and the culture was continued for an additional 15 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が120単
位/ml含有されていた。
The culture solution contained 120 units/ml of the physiologically active substance SPF-1.

実施例 8 下記の培地G2lに、 BHI 3.7% ポリペプトン 0.5% マルトース 0.3% KH2PO4 0.1% MgSO4・7H2O 0.02% PH=7.1 Streptococcus pyogenes ATCC21060を実施
例1と同様にして前培養した培養液100mlを接種
し、37℃、15hr撹拌しながら嫌気的に培養後、ペ
ニシリンG1000単位/mlを添加し、更に培養を
5hr継続する。得られた培養液を遠心分離し、菌
体を除去した。
Example 8 BHI 3.7% Polypeptone 0.5% Maltose 0.3% KH 2 PO 4 0.1% MgSO 4 7H 2 O 0.02% PH = 7.1 Streptococcus pyogenes ATCC21060 was precultured in the same manner as in Example 1 in the following medium G2l. After inoculating 100ml of the solution and culturing anaerobically at 37℃ for 15 hours with stirring, add 1000 units/ml of penicillin G and continue culturing.
Continues for 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液には生理活性物質SPF−1が300単
位/ml含有されていた。
The culture solution contained 300 units/ml of the physiologically active substance SPF-1.

実施例 9 前記培地E3lに、 Streptococcus pyogenes ATCC21060を、37
℃で8hr静置培養して得た種培養液300mlを添加接
種し37℃、15hr撹拌しながら嫌気的に培養後、ペ
ニシリンG1000単位/mlを添加し、更に培養を
5hr継続する。得られた培養液を遠心分離し、菌
体を除去した。
Example 9 Streptococcus pyogenes ATCC21060 was added to the medium E3l.
Add and inoculate 300 ml of seed culture obtained by static culture at 37°C for 8 hours. After culturing anaerobically at 37°C for 15 hours with stirring, add 1000 units/ml of penicillin G and continue culturing.
Continues for 5 hours. The obtained culture solution was centrifuged to remove bacterial cells.

培養液3には生理活性物質SPF−1を56×
104単位含有していた。
Culture solution 3 contains 56x the physiologically active substance SPF-1.
It contained 10 4 units.

培養液には硫安を添加し50〜80%飽和度の画
分を分取して、沈澱物を得た。この沈澱物は生理
活性物質SPF−1を50×104単位含有していた。
Ammonium sulfate was added to the culture solution, and a fraction with a saturation level of 50 to 80% was collected to obtain a precipitate. This precipitate contained 50×10 4 units of the physiologically active substance SPF-1.

この沈澱物全量を安定剤含有緩衝液300mlに溶
解し、溶解液をDEAE−セルロースカラム(5×
70cm)に加え、生理活性物質SPF−1を吸着させ
た。これに0.3MNaCl溶液を用いて段階的に溶出
させ、活性部分を分取する。得られた活性は30×
104単位であつた。
The entire amount of this precipitate was dissolved in 300 ml of stabilizer-containing buffer, and the solution was transferred to a DEAE-cellulose column (5x
70 cm), and the physiologically active substance SPF-1 was adsorbed. This is eluted stepwise using a 0.3M NaCl solution, and the active portion is separated. The activity obtained is 30×
It was 10 4 units.

活性部分を緩衝液に対して透析し、次に、
DEAE−セフアデツクスA−25のカラム(2.6×
50cm)に加え、活性部分を吸着させ、これに燐酸
緩衝液中の食塩濃度を直線的に上昇させつつ溶出
を行い、活性部分を分取する。得られた活性は
10.6×104単位であつた。
The active moiety is dialyzed against buffer, then
DEAE-Sephadex A-25 column (2.6×
50 cm), the active moiety is adsorbed, and the active moiety is fractionated by elution while linearly increasing the salt concentration in the phosphate buffer. The activity obtained is
It was 10.6×10 4 units.

更に、この溶出液を濃縮しゲル過材トヨパー
ルHW−50Fのカラム(2×100cm)に加え、活
性画分を分取する。得られた活性は2.2×104単位
であつた。
Furthermore, this eluate is concentrated and applied to a column (2 x 100 cm) of gel filtration material Toyopearl HW-50F to separate the active fraction. The activity obtained was 2.2×10 4 units.

ここに得られた溶出液を凍結乾燥し生理活性物
質SPF−1の白色粉末350mgを得た。
The eluate thus obtained was freeze-dried to obtain 350 mg of a white powder of the physiologically active substance SPF-1.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は生理活性物質SPF−13.3%水溶液の紫
外線吸収スペクトルを示し、第2図は同じく3.1
%水溶液の紫外線吸収スペクトルを示し、第3図
は同じく赤外線吸収スペクトルを示す。
Figure 1 shows the ultraviolet absorption spectrum of the physiologically active substance SPF-13.3% aqueous solution, and Figure 2 shows the same 3.1% ultraviolet absorption spectrum.
% aqueous solution, and FIG. 3 also shows the infrared absorption spectrum.

Claims (1)

【特許請求の範囲】[Claims] 1 ストレプトコツカス属に属する細菌を培養す
るに際し、培養中対数増殖期にかかつて後3〜15
時間の間にペニシリンを100〜3000単位/ml添加
して培養し、各種菌体生産物を菌体外に排出せし
めることを特徴とするストレプトコツカス属細菌
の培養法。
1. When culturing bacteria belonging to the genus Streptococcus, it is necessary to
1. A method for culturing bacteria of the genus Streptococcus, which comprises adding 100 to 3000 units/ml of penicillin for culturing and expelling various bacterial cell products from the bacterial cells.
JP13938483A 1983-08-01 1983-08-01 Cultivation of bacteria belonging to streptococcus genus Granted JPS6030677A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP13938483A JPS6030677A (en) 1983-08-01 1983-08-01 Cultivation of bacteria belonging to streptococcus genus
CA000459394A CA1237085A (en) 1983-08-01 1984-07-20 Spf-100 and process for the preparation thereof
GB08418745A GB2146028B (en) 1983-08-01 1984-07-23 Spf-100 and process for the preparation thereof
AU31000/84A AU572529B2 (en) 1983-08-01 1984-07-24 Spf-100 and process for the preparation thereof
CH3684/84A CH663033A5 (en) 1983-08-01 1984-07-30 SUBSTANCE-MIXTURE SAID "SPF-100" AND PROCESS FOR ITS PREPARATION.
DE19843428017 DE3428017A1 (en) 1983-08-01 1984-07-30 SPF-100 AND METHOD FOR THE PRODUCTION THEREOF
KR1019840004559A KR850002276A (en) 1983-08-01 1984-07-31 Manufacturing method of SPF-100
NL8402388A NL8402388A (en) 1983-08-01 1984-07-31 MEDICINAL PRODUCT SPF-100 AND METHOD FOR PREPARING THE SAME
FR8412119A FR2550223B1 (en) 1983-08-01 1984-07-31 SPF-100 AND PREPARATION PROCESS
SE8403914A SE461532B (en) 1983-08-01 1984-07-31 ANTI-CANCER AND IMMUNACTIVE SUBSTANCES (SPF-100)
US06/746,514 US4656037A (en) 1983-08-01 1985-06-19 SPF-100 and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13938483A JPS6030677A (en) 1983-08-01 1983-08-01 Cultivation of bacteria belonging to streptococcus genus

Publications (2)

Publication Number Publication Date
JPS6030677A JPS6030677A (en) 1985-02-16
JPH026511B2 true JPH026511B2 (en) 1990-02-09

Family

ID=15244054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13938483A Granted JPS6030677A (en) 1983-08-01 1983-08-01 Cultivation of bacteria belonging to streptococcus genus

Country Status (1)

Country Link
JP (1) JPS6030677A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5615685A (en) * 1979-07-16 1981-02-14 Chugai Pharmaceut Co Ltd Induction of l-form bacterium of hemolytic streptococcus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5615685A (en) * 1979-07-16 1981-02-14 Chugai Pharmaceut Co Ltd Induction of l-form bacterium of hemolytic streptococcus

Also Published As

Publication number Publication date
JPS6030677A (en) 1985-02-16

Similar Documents

Publication Publication Date Title
US4242326A (en) Anti-tumor substance and process for preparing the same
PL140807B1 (en) Method of obtaining a protein capable of lovering cholesterol level in blood
JP2787446B2 (en) AB-006 antibiotic and method for producing the same
US4656037A (en) SPF-100 and process for the preparation thereof
JPH026511B2 (en)
JPS60246396A (en) Enzyme-inhibiting substance dihydrodesoxy griseolic acid and its salt
JPH0881378A (en) Human epidermal keratinized cell activator
JPS6250475B2 (en)
JPS6326994B2 (en)
JPH0155275B2 (en)
JPS6092218A (en) Production of antitumor substance
JPH0156078B2 (en)
JPH0156077B2 (en)
JPH0998779A (en) Trehalose synthetase, its production and production of trehalose using the enzyme
JPH0155274B2 (en)
JPH0155276B2 (en)
Mostafa et al. Inhibition of ribosomal polyphenylalanine synthesis by soluble fractions from Escherichia coli B
JP3079183B2 (en) Production method of brown algae decomposition product
AT390268B (en) DNA from Penicillium chrysogenum and protein for which this DNA codes
JPH0260318B2 (en)
JP2690779B2 (en) L-ascorbic acid derivative and method for producing the same
JPS5594393A (en) Gluco-corticoid sparing factor
JPH0763365B2 (en) Yeast cell wall lysing enzyme and method for extracting yeast cell component using the same
FUJIWARA-ARASAKI et al. LYSINE-LACTOSE BROWNING PRODUCTS I. PROPERTIES OF THE REACTION PRODUCTS
COULSON LYSINE-LACTOSE BROWNING PRODUCTS